65 results
Page 3 of 4
8-K
EX-99
i1v xvcpbfyg7c
12 Nov 19
Cue Biopharma Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-1.1
fkvt62povtgwy61ths
5 Jun 19
Entry into a Material Definitive Agreement
8:55am
424B5
lp2j8 prt
5 Jun 19
Prospectus supplement for primary offering
8:49am
424B3
rkzj3 nhhvnzb8nef70h
8 Feb 19
Prospectus supplement
4:16pm
S-3
zs2eeljajpukypd84 a2
4 Jan 19
Shelf registration
5:02pm
8-K/A
EX-10.1
ux8du0yo
26 Dec 18
Cue Biopharma and LG Chem Life Sciences Announce WT1
4:31pm
8-K/A
EX-99.1
si9xg1tm
26 Dec 18
Cue Biopharma and LG Chem Life Sciences Announce WT1
4:31pm
8-K/A
EX-10.1
wabv5 7m38qrc
13 Nov 18
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-99.1
bery1ln8xgvrta
8 Nov 18
Entry into a Material Definitive Agreement
8:13am
424B3
tvy2acd x2
23 Jul 18
Prospectus supplement
4:44pm
8-K
EX-99
u1quo xlq
12 Jul 18
Cue Biopharma Produces Immuno-STATTM Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
8:40am
8-K
EX-10.1
yliobh p0
20 Jun 18
Entry into a Material Definitive Agreement
12:00am